Key Metrics of LivaNova
Revenue$1.2B▲ 12.9% YoYFY 2023
Operating income−$68.5M▲ 10.8% YoY
Net profit$17.6M▲ 120.4% YoY
Shareholders' equity$1.3B
Market cap$4.5BLIVN · $81.27
About LivaNova
Company details
- Website
- livanova.com
- Listed
- Nasdaq: LIVN
Company summary
Legal nameLivaNova PLC
TickerLIVN
ExchangeNasdaq
CountryUnited Kingdom
SEC CIK0001639691
Listed since—
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
SectorOther Industries · Discovered Companies
Websitehttp://www.livanova.com
US market & SEC filings
LIVN · Nasdaq · SEC CIK 0001639691
Last price · 24 Oct 2026
$81.27
+3.61%
Market cap$4.5B
P/E254.0On FY 2023 diluted EPS
Volume523,012
SectorHealth CareBiotechnology: Electromedical & Electrotherapeutic Apparatus
Country · IPOUnited Kingdom
LIVN share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeLondon
GSTIN—
Email—
Websitehttp://www.livanova.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.